Navigation path

Tuberculosis Projects

List of Tuberculosis projects sorted by Acronym

ADVAC-EC Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty
AFTBVAC Development of a Tuberculosis Vaccine in Africa
BCGNSE BCG Vaccination and Childhood Morbidity and Mortality: Interventions with Possible Implications for Immunisation Policy in Developing Countries
CELL CYCLE & DORMANCY IN TB Regulation of the Cell Cycle and Dormancy in Mycobacterium Tuberculosis
COCONUTKIT Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis
CSI LTB The role of chromosome stability in persistence, latency and reactivation of Mycobacterium tuberculosis
DISSARM Development of Integrable Sensors for Screening of Antibiotic Resistance in Mycobacterium
DOT AFRICAN TRIAL A Multicentre Randomised Trial of Directly Observed Treatment for Tuberculosis Patients in Sub-Saharan Africa
EDCTP European and Developing Countries Clinical Trials Programme
FASTEST-TB Development and Clinical Evaluation of Fast Tests for Tuberculosis Diagnosis
ISCOTB Novel Approaches to Induce Mucosal Immunity Against TB Using the Combined Adjuvant Strategy of CTA-1 and ISCOMS
Immuno VacTB A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis
INNOVAC Highly Innovative Strategies for Vaccination to Poverty Related Diseases
LONG-DRUG Characterisation of Mycobacterium Tuberculosis Populations During Infection: A  Longitudinal Study on Drug Resistance Development
MM-TB Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes
Mol.Epidemology TB New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis
MUCOSAL TB VACCINE Role of Mucosal Immunity for Protection against Tuberculosis
MUVAPRED Mucosal Vaccines for Poverty Related Diseases
MYCOMANCY Transcriptional Regulation And Cellular Localisation Of Mycobacterial Cell Cycle Proteins During Dormancy
Neotim Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants
NEW ANTIMYCOBACTERIALS Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis
NEWTBDRUGS New Drugs for Persistent Tuberculosis: Exploitation of 3-D Structure of Novel Targets, Lead Optimisation and Functional In-Vivo Evaluation
NEWTBVAC Discovery and preclinical testing of new vaccine candidates for tuberculosis
NM4TB New Medicines for Tuberculosis
NOVSEC-TB Novel secretion systems of Mycobacterium tuberculosis and their role in host-pathogen interaction.
OFLOTUB A Multicentre, Randomised, Control Trial of Ofloxacine-Containing, Short-Course Regimen for the Treatment of Pulmonary Tuberculosis
PreMalStruct Structural analysis of the CSA binding interactions involved during pregnancy associated malaria
PERSISTENT TB Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection:  Crystallisation, Structure Determination and Functional Studies
PHARMA-PLANTA Recombinant Pharmaceuticals from Plants for Human Health
scrIN-SILICO Finding Promising Drug Candidates Against Tuberculosis with
Multidisciplinary Protocol Based Non-Conventional Search
SENSITIVE TARGETS Oxygen-Sensitive Enzymes of the Mevalonate-Independent Isoprenoid Biosynthesis Pathway as Targets for New Antimalarial and Anti-TB Drugs
SERO-TB Development of a Specific Serological Kit for the Diagnosis of TB
SN-TB DIAGNOSIS A System Approach to Optimising Diagnosis of Smear-Negative Tuberculosis in High and Low Prevalence Countries of South America
StopLATENT-TB “LATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium tuberculosis.”
TB prevention cluster New Strategies for Treatment and Prevention of Mycobacterial Diseases
TB Treatment Marker Establishing a TB Treatment Efficacy Marker
TB VACCINE CLUSTER A Cluster for Tuberculosis Vaccine Development
TBADAPT Effect of Genetic Variation in Mycobacterium Tuberculosis on Vaccine Escape and the Acquisition of Drug Resistance
TB-DRUG OLIGOCOLOR Development of a Molecular Platform for the Simultaneous Detection of Mycobacterium tuberculosis Resistance to Rifampicin and Fluoroquinolones
TBMACS Identification and characterisation of Mycobacterium tuberculosis virulence genes involved in macrophage parasitism
TB PAN-NET TB PAN-NET: Pan-European network for study and clinical management of drug resistant tuberculosis.
TB-trDNA Evaluation of Transrenal-DNA Detection to Diagnose Tuberculosis
TB-VAC TB-VAC: An Integrated Project for New Vaccines against Tuberculosis
TB-VIR Mycobacterium tuberculosis W-Beijing genetic diversity and differential virulence and immune responses
TM-REST TM-REST: a new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malaria
Tuberculosis China The Diversity of Mycobacterium Tuberculosis Strains in China: Tracing the Origins of the Worldwide Dispersion of the Multidrug-Resistant Beijing Genotype
Upgrade Diagno MDR-TB Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America
Vaccines4TB Genome- and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis
VACSEL Longitudinal Study of Correlates of Immunity to Tuberculosis in Exposed Individuals
VACSIS Host-Parasite Relationship in Susceptibility to Tuberculosis
X-TB Structural and Functional Genomics of Mycobacterium Tuberculosis